Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGOIS in cataract surgery
NCT00333268Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Sep 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Next Generation Ophthalmic Irrigating Solution in cataract (2 arms), sponsored by Alcon Inc. Primary endpoint: Percent change in endothelial cell density. Started Sep 2004; status: completed.
02
Drugs
Next Generation Ophthalmic Irrigating Solution
03
Conditions
cataract
Beyond the preview
Go deeper on NCT00333268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00333268.